ArticleScientific reports2026
Radioluminescence 3D dose reconstruction for FLASH and conventional radiotherapy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
FLASH radiotherapy requires dosimetric techniques capable of operating at ultra-high dose rates (UHDR), where conventional detectors often suffer from saturation, limited temporal resolution or lack of spatial information. Radioluminescence imaging (RLI) in plastic scintillators represents a promising alternative, enabling real-time and high-resolution visualization of dose deposition. In this work, we present a proof-of-concept methodology for three-dimensional (3D) dose reconstruction from radioluminescence images, exploiting cylindrical beam symmetry and inverse tomographic reconstruction. Three reconstruction algorithms (Fourier-based Abel inversion (FBAI), filtered back-projection (FBP) and maximum-likelihood expectation maximization (MLEM)) were first evaluated using Monte Carlo (MC) simulations to assess reconstruction accuracy against ground-truth dose distributions. Experimental validation was then performed using a plastic scintillator cube irradiated under UHDR conditions with a 9 MeV FLASH electron linac, as well as under conventional dose rate using a 6 MeV electron linac and a 6 MeV photon CyberKnife system. Radioluminescence images were acquired with a laterally positioned CMOS camera and reconstructed dose distributions were compared with Gafchromic (GC) film measurements using gamma index analysis and depth-dose profiles. All reconstruction methods successfully reproduced the global depth-dose behavior. Experimental results demonstrated good agreement with GC film dosimetry, with gamma values predominantly below unity and reconstructed profiles closely following reference measurements across different dose rates and field sizes. These findings demonstrate that radioluminescence-based 3D dose reconstruction is a viable and experimentally simple approach for dosimetry in both conventional and FLASH radiotherapy, offering a valuable complementary tool for beam monitoring and quality assurance in emerging UHDR applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.